Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
GLOBETECH PUBLISHING LLC
Schiller

Hidden Data Behind Imaging Scans for Cancer May offer New Radiotherapy Strategies

By Medimaging International staff writers
Posted on 30 Jul 2014
Information hidden in imaging tests could help clinicians more effectively choose the radiation therapy dose needed to kill tumors, suggests a study of more than 300 cancer patients.

The research, to be presented at the 56th annual meeting of the American Association of Physicists in Medicine (AAPM), held during July 28 to August 1, 2014, in Austin, TX, USA, is the largest study to date to use radiomics—extracting statistical data from images and other measurements—to help predict the probable progression of cancer or its response to treatment based on positron emission tomography (PET) imaging scans of patients with non-small-cell lung cancer and head and neck cancer.

“Currently, there is a one-size-fits-all process for selecting radiation therapy doses, which might be too much for some patients and not enough for others,” said Joseph Deasy, PhD, senior author of the study and chair of the department of medical physics at Memorial Sloan-Kettering Cancer Center (New York, NY, USA). “Radiomics will help us know when we can turn down the treatment intensity with confidence, knowing we can still control the disease.”

In the study, researchers performed PET scanning in 163 non-small-cell lung cancer patients and 174 head and neck cancer patients before and after treatment. They extracted a range of information from each tumor, including the intensity value of the PET image, the roughness of the image, and other information, such as how round the tumor was. In PET, the brighter an area is, the higher the intensity, revealing that the tumor is consuming a greater amount of energy from the injected radioactive glucose substitute tracer.

Comparing the data gathered from the before and after scans to how the patient fared—including whether the tumor shrank or how long the patient survived—researchers can create models that will help direct future therapy. In this study, for instance, researchers determined that lung tumors that have a higher uptake of the tracer need to be treated with a higher dose of radiation than is typically prescribed.

“Standard protocol today is to only use PET imaging to define the extent of a tumor to be treated,” said Dr. Deasy. “Based on the information from this study, the data would be extracted from those images and put into models that would tell the physician what dose was required to kill the tumor with a high probability.” He noted that radiomics is a team effort that requires good collaboration between physicians, physicists, and computer scientists.

Related Links:

Memorial Sloan-Kettering Cancer Center



Channels

Radiography

view channel

Pediatric Radiation Dose Reduction Key Factor in Selection of DR Systems

X-Ray dose reduction potential was a key factor in the decision of the Washington DC (USA) metropolitan area Children’s National Health System to install new Direct Radiography (DR) systems. The priority of Children’s National Health System was to ensure that pediatric patients would receive the lowest possible dose... Read more

MRI

view channel
Image: The Micronor M303 Encoding Sensor with A/B Quadrature Pulse Train Background (Photo courtesy of Micronor).

World’s First MRI-Safe Linear Encoder for Medical Applications Announced

A company specialized in producing fiber optic kinetic sensors, has developed a first-of-a-kind passive, optical, non-electronic, high-precision encoder for use in medical Magnetic Resonance Imaging (MRI).... Read more

Ultrasound

view channel
Image: The Lumify, app-based ultrasound system (Photo courtesy of Philips).

Philips Debuts First App-Based Ultrasound

An app-based ultrasound solution aims extending the reach of ultrasound applications using mobile technology. The app was presented at the Social Media and Critical Care conference, June, 23–26, 2015... Read more

Nuclear medicine

view channel

Hybrid Scanner Using Five Molecular Imaging Techniques Under Development

Scientists are developing a new molecular, preclinical hybrid imaging system to help find new drugs and to advance imaging research. The scanner was presented at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI; Reston, Virginia, USA), and consists of a window for tissue observation,... Read more

General/Advanced Imaging

view channel

FDA Approves Trial for Intraoperative Image-Guided Cancer Surgery System

The US Food and Drug Administration (FDA) has provided Investigational Device Exemption (IDE) approval for company to trial a new image-guided cancer surgery system for intraoperative imaging of breast cancer. The surgical system consists of a cancer-specific molecular imaging agent, and a lightweight hand-held single-cell... Read more

Industry News

view channel
Image: The Westchester Medical Center in Valhalla, NY, USA (Photo courtesy of Business Wire).

Philips to Provide Multi-Year USD 500 Million in Healthcare Services in the USA

Royal Philips (Amsterdam, the Netherlands) and the Westchester Medical Center Health Network (WMCHealth; Valhalla, NY, USA) have announced USD 500 million multi-year partnership. Philips will provide... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.